Market Neuron Logo
⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.

ERIS - Swing Trade Analysis with AI Signals

Last Updated Time : 20 Dec 25, 07:01 am

Back to Swing Trade List

Swing Trade Rating: 3.4

Stock Code ERIS Market Cap 21,478 Cr. Current Price 1,577 ₹ High / Low 1,910 ₹
Stock P/E 76.2 Book Value 203 ₹ Dividend Yield 0.47 % ROCE 6.86 %
ROE 3.02 % Face Value 1.00 ₹ DMA 50 1,603 ₹ DMA 200 1,564 ₹
Chg in FII Hold -1.18 % Chg in DII Hold 1.18 % PAT Qtr 150 Cr. PAT Prev Qtr 100.0 Cr.
RSI 44.5 MACD -10.2 Volume 18,565 Avg Vol 1Wk 49,024
Low price 1,097 ₹ High price 1,910 ₹ PEG Ratio -1.76 Debt to equity 0.79
52w Index 59.0 % Qtr Profit Var 432 % EPS 20.7 ₹ Industry PE 30.6

📊 ERIS shows limited potential for swing trading. While the company has posted strong quarterly profit growth (432% variation), its fundamentals are weak with low ROCE (6.86%) and ROE (3.02%). The high P/E ratio (76.2 vs industry 30.6) indicates overvaluation. Technical indicators (RSI 44.5, MACD negative) suggest weak momentum. Optimal entry would be near 1,520–1,540 ₹. If already holding, consider exiting around 1,700–1,750 ₹ if momentum improves.

✅ Positive

⚠️ Limitation

🚨 Company Negative News

No major negative news reported, but weak fundamentals and reduced FII holdings (-1.18%) raise caution.

🌟 Company Positive News

Strong quarterly profit growth and rising DII interest highlight resilience despite valuation concerns.

🏭 Industry

The pharmaceutical industry trades at an average P/E of 30.6. ERIS trades at a steep premium, reflecting growth expectations but also significant overvaluation risk.

📌 Conclusion

ERIS is a risky candidate for swing trading due to weak fundamentals and high valuation. Entry near 1,520–1,540 ₹ is optimal for risk-tolerant traders. Exit strategy should target 1,700–1,750 ₹ if momentum strengthens. Caution is advised given overvaluation and weak technical indicators.

I can also prepare a comparison with other pharma stocks trading at similar valuations so you can see if ERIS offers better or worse swing trade potential. Would you like me to set that up?

Back to Swing Trade List

NIFTY 50 - Today Top Swing Trade Stock Picks

NEXT 50 - Today Top Swing Trade Stock Picks

MIDCAP - Today Top Swing Trade Stock Picks

SMALLCAP - Today Top Swing Trade Stock Picks